Concepts (173)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Phototherapy | 7 | 2021 | 28 | 0.930 |
Why?
|
| Bilirubin | 8 | 2021 | 51 | 0.760 |
Why?
|
| Infant, Newborn | 27 | 2022 | 2455 | 0.740 |
Why?
|
| Weight Loss | 7 | 2017 | 319 | 0.690 |
Why?
|
| Breast Feeding | 5 | 2017 | 159 | 0.580 |
Why?
|
| Birth Weight | 9 | 2017 | 186 | 0.530 |
Why?
|
| Nomograms | 4 | 2016 | 19 | 0.520 |
Why?
|
| California | 16 | 2018 | 99 | 0.520 |
Why?
|
| Respiratory Syncytial Virus Infections | 4 | 2018 | 12 | 0.520 |
Why?
|
| Infant, Premature | 9 | 2017 | 284 | 0.440 |
Why?
|
| Asthma | 5 | 2018 | 345 | 0.420 |
Why?
|
| Hyperbilirubinemia, Neonatal | 3 | 2016 | 6 | 0.410 |
Why?
|
| Sepsis | 3 | 2022 | 233 | 0.370 |
Why?
|
| Cesarean Section | 4 | 2018 | 101 | 0.340 |
Why?
|
| Postpartum Hemorrhage | 3 | 2019 | 12 | 0.340 |
Why?
|
| Neonatal Sepsis | 2 | 2020 | 3 | 0.330 |
Why?
|
| Hyperbilirubinemia | 3 | 2018 | 12 | 0.320 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2022 | 154 | 0.310 |
Why?
|
| Immunization | 2 | 2018 | 86 | 0.280 |
Why?
|
| Retrospective Studies | 18 | 2022 | 7277 | 0.270 |
Why?
|
| Blood Culture | 3 | 2022 | 15 | 0.270 |
Why?
|
| Anti-Bacterial Agents | 6 | 2022 | 1026 | 0.260 |
Why?
|
| Cohort Studies | 11 | 2021 | 2358 | 0.240 |
Why?
|
| Infant, Premature, Diseases | 3 | 2013 | 85 | 0.230 |
Why?
|
| Female | 31 | 2022 | 38074 | 0.230 |
Why?
|
| Cerebral Palsy | 3 | 2015 | 24 | 0.230 |
Why?
|
| Neonatal Screening | 2 | 2021 | 43 | 0.230 |
Why?
|
| Jaundice, Neonatal | 3 | 2016 | 8 | 0.210 |
Why?
|
| Neonatal Abstinence Syndrome | 1 | 2022 | 27 | 0.210 |
Why?
|
| Delivery, Obstetric | 3 | 2016 | 58 | 0.200 |
Why?
|
| Risk Factors | 13 | 2018 | 5731 | 0.200 |
Why?
|
| Humans | 37 | 2022 | 68618 | 0.200 |
Why?
|
| Risk Assessment | 6 | 2019 | 2007 | 0.200 |
Why?
|
| Spherocytosis, Hereditary | 1 | 2021 | 2 | 0.200 |
Why?
|
| Hospitalization | 2 | 2018 | 978 | 0.200 |
Why?
|
| Male | 26 | 2021 | 37321 | 0.200 |
Why?
|
| Blood Cell Count | 1 | 2021 | 35 | 0.200 |
Why?
|
| Antigens, CD34 | 1 | 2021 | 75 | 0.190 |
Why?
|
| Infant | 8 | 2022 | 2891 | 0.180 |
Why?
|
| Aftercare | 1 | 2021 | 114 | 0.180 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2020 | 62 | 0.180 |
Why?
|
| Bacteremia | 1 | 2022 | 155 | 0.170 |
Why?
|
| Leukapheresis | 1 | 2019 | 8 | 0.170 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2021 | 268 | 0.170 |
Why?
|
| Obstetric Labor Complications | 1 | 2019 | 20 | 0.160 |
Why?
|
| Puerperal Disorders | 1 | 2019 | 20 | 0.160 |
Why?
|
| Pregnancy | 7 | 2022 | 2334 | 0.160 |
Why?
|
| Bacteria | 1 | 2020 | 193 | 0.160 |
Why?
|
| Bronchiolitis, Viral | 1 | 2018 | 1 | 0.160 |
Why?
|
| Respiratory Syncytial Viruses | 1 | 2018 | 9 | 0.160 |
Why?
|
| Early Diagnosis | 1 | 2019 | 122 | 0.160 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2019 | 124 | 0.160 |
Why?
|
| International Classification of Diseases | 1 | 2018 | 85 | 0.150 |
Why?
|
| Incidence | 6 | 2016 | 1603 | 0.140 |
Why?
|
| Patient Outcome Assessment | 1 | 2017 | 42 | 0.140 |
Why?
|
| Gestational Age | 5 | 2020 | 389 | 0.140 |
Why?
|
| Pregnancy Complications, Hematologic | 1 | 2016 | 15 | 0.140 |
Why?
|
| Respiratory Syncytial Virus, Human | 1 | 2016 | 11 | 0.140 |
Why?
|
| Hemoglobins | 1 | 2016 | 120 | 0.130 |
Why?
|
| Epilepsies, Myoclonic | 1 | 2015 | 8 | 0.130 |
Why?
|
| Anemia | 1 | 2016 | 104 | 0.130 |
Why?
|
| Maternal Exposure | 1 | 2016 | 75 | 0.130 |
Why?
|
| Kernicterus | 1 | 2015 | 7 | 0.130 |
Why?
|
| Electronic Health Records | 1 | 2019 | 374 | 0.130 |
Why?
|
| Bottle Feeding | 1 | 2015 | 20 | 0.130 |
Why?
|
| Follow-Up Studies | 6 | 2018 | 3259 | 0.120 |
Why?
|
| Autism Spectrum Disorder | 1 | 2016 | 111 | 0.120 |
Why?
|
| Child, Preschool | 6 | 2018 | 3187 | 0.120 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2015 | 110 | 0.120 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2013 | 26 | 0.110 |
Why?
|
| Respiratory Sounds | 1 | 2013 | 35 | 0.110 |
Why?
|
| Bronchiolitis | 1 | 2013 | 3 | 0.110 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2017 | 468 | 0.110 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 2013 | 72 | 0.110 |
Why?
|
| Proportional Hazards Models | 4 | 2016 | 792 | 0.110 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2016 | 529 | 0.100 |
Why?
|
| Time Factors | 5 | 2020 | 4655 | 0.100 |
Why?
|
| Decision Support Techniques | 1 | 2013 | 191 | 0.100 |
Why?
|
| Multivariate Analysis | 4 | 2016 | 1046 | 0.100 |
Why?
|
| Predictive Value of Tests | 4 | 2018 | 1465 | 0.090 |
Why?
|
| Child | 5 | 2018 | 6405 | 0.080 |
Why?
|
| Adult | 8 | 2021 | 21403 | 0.080 |
Why?
|
| Maternal Age | 2 | 2018 | 70 | 0.070 |
Why?
|
| Patient Discharge | 2 | 2021 | 294 | 0.070 |
Why?
|
| Logistic Models | 3 | 2016 | 1420 | 0.070 |
Why?
|
| Models, Theoretical | 2 | 2021 | 384 | 0.070 |
Why?
|
| Exchange Transfusion, Whole Blood | 2 | 2015 | 13 | 0.060 |
Why?
|
| Sensitivity and Specificity | 2 | 2021 | 1753 | 0.060 |
Why?
|
| Pregnancy Complications | 2 | 2019 | 286 | 0.060 |
Why?
|
| Neoplasms | 1 | 2016 | 1667 | 0.060 |
Why?
|
| Young Adult | 3 | 2021 | 5717 | 0.060 |
Why?
|
| Case-Control Studies | 3 | 2015 | 1553 | 0.060 |
Why?
|
| Odds Ratio | 2 | 2016 | 880 | 0.050 |
Why?
|
| Coagulase | 1 | 2022 | 14 | 0.050 |
Why?
|
| Staphylococcus | 1 | 2022 | 29 | 0.050 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2003 | 92 | 0.050 |
Why?
|
| Erythrocyte Indices | 1 | 2021 | 9 | 0.050 |
Why?
|
| Likelihood Functions | 1 | 2021 | 106 | 0.050 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 1 | 2021 | 29 | 0.050 |
Why?
|
| Mothers | 1 | 2022 | 172 | 0.050 |
Why?
|
| Blood Component Removal | 1 | 2021 | 19 | 0.050 |
Why?
|
| Severity of Illness Index | 2 | 2019 | 1851 | 0.050 |
Why?
|
| Cell Count | 1 | 2021 | 248 | 0.050 |
Why?
|
| Age Factors | 2 | 2015 | 1864 | 0.040 |
Why?
|
| Prognosis | 2 | 2016 | 2093 | 0.040 |
Why?
|
| Forecasting | 1 | 2021 | 277 | 0.040 |
Why?
|
| Tissue Donors | 1 | 2021 | 195 | 0.040 |
Why?
|
| Maternal Death | 1 | 2019 | 1 | 0.040 |
Why?
|
| Cardiotocography | 1 | 2019 | 3 | 0.040 |
Why?
|
| Uterine Rupture | 1 | 2019 | 4 | 0.040 |
Why?
|
| Uterine Hemorrhage | 1 | 2019 | 16 | 0.040 |
Why?
|
| Leukocyte Count | 1 | 2019 | 94 | 0.040 |
Why?
|
| Eclampsia | 1 | 2019 | 16 | 0.040 |
Why?
|
| Fetal Death | 1 | 2019 | 49 | 0.040 |
Why?
|
| Automation | 1 | 2019 | 45 | 0.040 |
Why?
|
| Embolism | 1 | 2019 | 45 | 0.040 |
Why?
|
| Obstetrics | 1 | 2019 | 44 | 0.040 |
Why?
|
| Cytokines | 1 | 2003 | 866 | 0.040 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2019 | 56 | 0.040 |
Why?
|
| Parity | 1 | 2018 | 71 | 0.040 |
Why?
|
| Blood Coagulation Disorders | 1 | 2018 | 45 | 0.040 |
Why?
|
| Seasons | 1 | 2018 | 129 | 0.040 |
Why?
|
| Hysterectomy | 1 | 2018 | 64 | 0.040 |
Why?
|
| Critical Illness | 1 | 2019 | 191 | 0.040 |
Why?
|
| Analgesics, Opioid | 1 | 2022 | 498 | 0.040 |
Why?
|
| Biomarkers | 2 | 2018 | 1593 | 0.040 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2018 | 77 | 0.040 |
Why?
|
| Paternal Age | 1 | 2016 | 1 | 0.040 |
Why?
|
| Regression Analysis | 1 | 2019 | 737 | 0.040 |
Why?
|
| Pre-Eclampsia | 1 | 2019 | 202 | 0.040 |
Why?
|
| Spectrophotometry | 1 | 2016 | 54 | 0.030 |
Why?
|
| Tennessee | 1 | 2016 | 11 | 0.030 |
Why?
|
| Calibration | 1 | 2016 | 73 | 0.030 |
Why?
|
| Antiviral Agents | 1 | 2018 | 211 | 0.030 |
Why?
|
| Reference Standards | 1 | 2016 | 115 | 0.030 |
Why?
|
| Propensity Score | 1 | 2016 | 117 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 2279 | 0.030 |
Why?
|
| Siblings | 1 | 2016 | 34 | 0.030 |
Why?
|
| NAV1.1 Voltage-Gated Sodium Channel | 1 | 2015 | 1 | 0.030 |
Why?
|
| Educational Status | 1 | 2016 | 273 | 0.030 |
Why?
|
| Urinary Tract Infections | 1 | 2016 | 71 | 0.030 |
Why?
|
| Monitoring, Physiologic | 1 | 2016 | 219 | 0.030 |
Why?
|
| Infant Formula | 1 | 2015 | 24 | 0.030 |
Why?
|
| Microbiota | 1 | 2016 | 80 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2015 | 112 | 0.030 |
Why?
|
| Glucosephosphate Dehydrogenase Deficiency | 1 | 2014 | 10 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2018 | 7029 | 0.030 |
Why?
|
| Aged | 2 | 2021 | 14862 | 0.030 |
Why?
|
| Watchful Waiting | 1 | 2013 | 25 | 0.030 |
Why?
|
| Medicaid | 1 | 2016 | 302 | 0.030 |
Why?
|
| Patient Readmission | 1 | 2016 | 267 | 0.030 |
Why?
|
| Age of Onset | 1 | 2013 | 188 | 0.030 |
Why?
|
| United States | 2 | 2016 | 7367 | 0.030 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2013 | 46 | 0.030 |
Why?
|
| Length of Stay | 1 | 2016 | 780 | 0.030 |
Why?
|
| Sex Factors | 1 | 2016 | 1266 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 1745 | 0.030 |
Why?
|
| Middle Aged | 2 | 2021 | 21147 | 0.030 |
Why?
|
| Risk | 1 | 2013 | 563 | 0.020 |
Why?
|
| Body Weight | 1 | 2013 | 554 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 772 | 0.020 |
Why?
|
| Recurrence | 1 | 2013 | 948 | 0.020 |
Why?
|
| Obesity | 1 | 2018 | 1076 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 4848 | 0.020 |
Why?
|
| Prevalence | 1 | 2013 | 1619 | 0.020 |
Why?
|
| Adolescent | 1 | 2021 | 8912 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 2077 | 0.020 |
Why?
|
| Algorithms | 1 | 2013 | 1196 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2015 | 2223 | 0.020 |
Why?
|
| Chromatography, Affinity | 1 | 2003 | 73 | 0.010 |
Why?
|
| Skull | 1 | 2003 | 63 | 0.010 |
Why?
|
| Medical Records | 1 | 2003 | 121 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2003 | 453 | 0.010 |
Why?
|